Literature DB >> 19232506

Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period.

Hironori Nagasaka1, Yoshiyuki Okano, Hirokazu Tsukahara, Yosuke Shigematsu, Toru Momoi, Junko Yorifuji, Takashi Miida, Toshihiro Ohura, Keiko Kobayashi, Takeyori Saheki, Kenichi Hirano, Masaki Takayanagi, Tohru Yorifuji.   

Abstract

Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) shows diverse metabolic abnormalities such as urea cycle dysfunction together with citrullinemia, galactosemia, and suppressed gluconeogenesis. Such abnormalities apparently resolve during the first year of life. However, metabolic profiles of the silent period remain unknown. We analyzed oxidative stress markers and profiles of amino acids, carbohydrates, and lipids in 20 asymptomatic children with aspartate/glutamate carrier isoform 2-citrin-deficiency aged 1-10 years, for whom tests showed normal liver function. Despite normal plasma ammonia levels, the affected children showed higher blood levels of ornithine (p<0.001) and citrulline (p<0.01)--amino acids involved in the urea cycle--than healthy children. Blood levels of nitrite/nitrate, metabolites of nitric oxide (NO), and asymmetric dimethylarginine inhibiting NO production from arginine were not different between these two groups. Blood glucose, galactose, pyruvate, and lactate levels after 4-5h fasting were not different between these groups, but the affected group showed a significantly higher lactate to pyruvate ratio. Low-density and high-density lipoprotein cholesterol levels in the affected group were 1.5 times higher than those in the controls. Plasma oxidized low-density lipoprotein apparently increased in the affected children; their levels of urinary oxidative stress markers such as 8-hydroxy-2'-deoxyguanosine and acrolein-lysine were significantly higher than those in the controls. Results of this study showed, even during the silent period, sustained hypercitrullinemia, hypercholesterolemia, and augmented oxidative stress in children with citrin deficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232506     DOI: 10.1016/j.ymgme.2009.01.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.

Authors:  Carlos J Perez; Jean Jaubert; Jean-Louis Guénet; Kirstin F Barnhart; Catherine M Ross-Inta; Vicente C Quintanilla; Isabelle Aubin; Jimi L Brandon; Nancy W Otto; John DiGiovanni; Irma Gimenez-Conti; Cecilia Giulivi; Donna F Kusewitt; Claudio J Conti; Fernando Benavides
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.

Authors:  Kiyoshi Hayasaka; Chikahiko Numakura; Mitsunori Yamakawa; Tetsuo Mitsui; Hisayoshi Watanabe; Hiroaki Haga; Masahide Yazaki; Hiromasa Ohira; Yasuo Ochiai; Toshiyuki Tahara; Tamio Nakahara; Noriyo Yamashiki; Takahiro Nakayama; Takashi Kon; Hiroshi Mitsubuchi; Hiroshi Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-04-12       Impact factor: 4.982

3.  Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature.

Authors:  Daniel B Larach; W Andrew Kofke; Peter Le Roux
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

4.  Prediction of the functional effect of novel SLC25A13 variants using a S. cerevisiae model of AGC2 deficiency.

Authors:  Parith Wongkittichote; Sumalee Tungpradabkul; Duangrurdee Wattanasirichaigoon; Laran T Jensen
Journal:  J Inherit Metab Dis       Date:  2012-10-03       Impact factor: 4.982

Review 5.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

Review 6.  Metabolic dysregulation in monogenic disorders and cancer - finding method in madness.

Authors:  Ayelet Erez; Ralph J DeBerardinis
Journal:  Nat Rev Cancer       Date:  2015-06-18       Impact factor: 69.800

7.  SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China.

Authors:  Yuan-Zong Song; Zhan-Hui Zhang; Wei-Xia Lin; Xin-Jing Zhao; Mei Deng; Yan-Li Ma; Li Guo; Feng-Ping Chen; Xiao-Ling Long; Xiang-Ling He; Yoshihide Sunada; Shun Soneda; Akiko Nakatomi; Sumito Dateki; Lock-Hock Ngu; Keiko Kobayashi; Takeyori Saheki
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

8.  Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance.

Authors:  Han-Shi Zeng; Shu-Tao Zhao; Mei Deng; Zhan-Hui Zhang; Xiang-Ran Cai; Feng-Ping Chen; Yuan-Zong Song
Journal:  Int J Mol Med       Date:  2014-09-10       Impact factor: 4.101

9.  A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?

Authors:  Jiayi He; Jianling Zhang; Xuesong Li; Hong Wang; Cui Feng; Feng Fang; Sainan Shu
Journal:  Front Pediatr       Date:  2019-09-18       Impact factor: 3.418

Review 10.  Inborn disorders of the malate aspartate shuttle.

Authors:  Melissa H Broeks; Clara D M van Karnebeek; Ronald J A Wanders; Judith J M Jans; Nanda M Verhoeven-Duif
Journal:  J Inherit Metab Dis       Date:  2021-05-24       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.